Rankings
▼
Calendar
PRAX Q3 2025 Earnings — Praxis Precision Medicines, Inc. Revenue & Financial Results | Market Cap Arena
PRAX
Praxis Precision Medicines, Inc.
$7B
Q3 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
-100.0% YoY
Gross Profit
-$66M
Operating Income
-$78M
Net Income
-$74M
EPS (Diluted)
$-3.36
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$65M
Free Cash Flow
-$65M
Stock-Based Comp.
$7M
Balance Sheet
Total Assets
$396M
Total Liabilities
$53M
Stockholders' Equity
$344M
Cash & Equivalents
$150M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$302,000
-100.0%
Gross Profit
-$66M
-$42M
-58.2%
Operating Income
-$78M
-$57M
-37.9%
Net Income
-$74M
-$52M
-42.4%
← FY 2025
All Quarters
Q4 2025 →